US SB3133 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on December 19 2019 - 25% progression, died in committee
Action: 2019-12-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 19 2019 - 25% progression, died in committee
Action: 2019-12-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs, and for other purposes.
Title
Conditional Approval Act
Sponsors
Sen. Mike Braun [R-IN] | Sen. Lisa Murkowski [R-AK] |
History
Date | Chamber | Action |
---|---|---|
2019-12-19 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB5497 (Related) 2019-12-20 - Referred to the Subcommittee on Health.
Subjects
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Health
Health care coverage and access
Health information and medical records
Licensing and registrations
Marketing and advertising
Medical research
Drug safety, medical device, and laboratory regulation
Health
Health care coverage and access
Health information and medical records
Licensing and registrations
Marketing and advertising
Medical research
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3133/all-info |
Text | https://www.congress.gov/116/bills/s3133/BILLS-116s3133is.pdf |